Nuzenio

Monte Rosa Therapeutics

Monte Rosa Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 10 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 09:13:44 GMTThe Manufacturers Life Insurance Company Raises Stake in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat
Sat, 08 Aug 2026 07:49:35 GMTDimensional Fund Advisors LP Acquires 473,005 Shares of Monte Rosa Therapeutics, Inc. $GLUE - MarketBeat
Sat, 08 Aug 2026 05:58:42 GMTMonte Rosa Therapeutics (GLUE) Stock Faces Mounting Loss Pressure - simplywall.st
Fri, 07 Aug 2026 18:44:16 GMTJPMorgan Chase & Co. Has Lowered Expectations for Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Price - MarketBeat
Fri, 07 Aug 2026 14:31:02 GMTMonte Rosa Therapeutics Is Maintained at Overweight by Wells Fargo - Moomoo
Fri, 07 Aug 2026 13:59:27 GMTWells Fargo & Company Lowers Monte Rosa Therapeutics (NASDAQ:GLUE) Price Target to $27.00 - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Monte Rosa Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.